CARRATU', Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 9.893
AS - Asia 3.896
EU - Europa 3.134
SA - Sud America 1.005
AF - Africa 146
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.088
Nazione #
US - Stati Uniti d'America 9.760
SG - Singapore 1.652
CN - Cina 929
IT - Italia 905
BR - Brasile 802
HK - Hong Kong 493
SE - Svezia 466
DE - Germania 358
RU - Federazione Russa 330
UA - Ucraina 251
FI - Finlandia 240
FR - Francia 212
VN - Vietnam 209
GB - Regno Unito 182
IN - India 128
BD - Bangladesh 73
AR - Argentina 69
IQ - Iraq 61
ID - Indonesia 57
CA - Canada 56
MX - Messico 43
TR - Turchia 43
EC - Ecuador 36
ZA - Sudafrica 36
JP - Giappone 34
IE - Irlanda 31
UZ - Uzbekistan 31
CO - Colombia 29
VE - Venezuela 29
ES - Italia 27
SA - Arabia Saudita 26
PK - Pakistan 25
BE - Belgio 24
CI - Costa d'Avorio 23
PL - Polonia 21
MA - Marocco 20
CZ - Repubblica Ceca 19
NL - Olanda 18
PH - Filippine 17
AT - Austria 15
MY - Malesia 15
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
KE - Kenya 12
PE - Perù 12
NP - Nepal 11
PY - Paraguay 11
DZ - Algeria 9
JO - Giordania 9
JM - Giamaica 8
AU - Australia 7
IL - Israele 7
LB - Libano 7
AZ - Azerbaigian 6
CH - Svizzera 6
CL - Cile 6
CR - Costa Rica 6
IR - Iran 6
BH - Bahrain 5
BO - Bolivia 5
ET - Etiopia 5
KZ - Kazakistan 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
UY - Uruguay 5
HN - Honduras 4
NG - Nigeria 4
PS - Palestinian Territory 4
TW - Taiwan 4
AL - Albania 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KR - Corea 2
ML - Mali 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
Totale 18.073
Città #
Fairfield 1.013
Ashburn 949
Woodbridge 863
Singapore 854
Chandler 831
Jacksonville 570
Houston 554
Hong Kong 493
San Jose 469
Seattle 429
Milan 391
Nyköping 362
Ann Arbor 353
Cambridge 348
Wilmington 313
Beijing 242
Roxbury 175
Lawrence 174
Nanjing 172
Lauterbourg 156
Dearborn 142
Des Moines 114
Rome 108
New York 103
Los Angeles 100
Boardman 97
Helsinki 94
Dallas 85
São Paulo 74
Brooklyn 67
Bari 64
Santa Clara 64
Columbus 60
Ho Chi Minh City 60
San Diego 52
Buffalo 46
Princeton 46
Hebei 44
Munich 42
Council Bluffs 40
Hanoi 40
London 39
Shenyang 39
Inglewood 36
Jiaxing 35
Jakarta 33
Turin 33
Tokyo 32
Dublin 31
Figino 29
Rio de Janeiro 29
Dong Ket 28
Nanchang 28
Chicago 26
Orem 26
Brussels 24
Abidjan 23
Atlanta 23
Hefei 23
Changsha 22
Tashkent 22
Baghdad 21
Taranto 21
Johannesburg 20
Turi 20
Belo Horizonte 19
Frankfurt am Main 19
Moscow 19
Paris 18
Guangzhou 17
Pune 17
Warsaw 17
Curitiba 16
Kunming 16
Phoenix 16
Tianjin 16
Toronto 16
Denver 15
Mexico City 15
Olomouc 15
Dhaka 14
Jinan 14
Montreal 14
Nuremberg 14
Redwood City 14
Stockholm 14
Brasília 13
Guayaquil 13
Mottola 13
New Delhi 13
Istanbul 12
Salvador 12
Boston 11
Chennai 11
Haiphong 11
Porto Alegre 11
Washington 11
Bologna 10
Campinas 10
Falkenstein 10
Totale 12.412
Nome #
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 262
Voluntary lung function screening to reveal new COPD cases in southern Italy 254
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 221
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 204
An Electronic Nose Discriminates between the Exhaled Breath of Patients with Pleural Malignant Mesothelioma and Healthy Controls, 189
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 186
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 179
Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia 177
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 175
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 170
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 170
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 167
And the patient said: Let me be able to breathe and dream 165
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 160
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 159
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 157
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 155
Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis 153
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 149
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 148
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 146
Enviromental asbestos exposure as a risk factor for small airways obstruction 144
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 144
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 141
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 141
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 141
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 141
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 140
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 138
An electronic nose may sniff out amyotrophic lateral sclerosis 136
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 133
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 132
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 132
Alterazioni del metabolismo dell'endotelina-1 in pazienti con tromboembolia polmonare 131
In vitro identification of new transcriptomic and miRNomic profiles associated with pulmonary fibrosis induced by high doses everolimus: Looking for new pathogenetic markers and therapeutic targets 131
A60 antigen, as a new tuberculin 130
Lack of association between OSAS and Hypothyroidism 130
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 130
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures 126
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 126
TITRATION EFFECTIVENESS OF TWO AUTOCPAP DEVICES DRIVEN BY DIFFERENT ALGORITHMS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA 123
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 123
Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression 122
Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. 121
Bilateral diaphragmatic paralysis after kidney surgery 121
24-hours Endothelin-1 urinary excretion in patients with Interstitial Lung Disease 119
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 119
Smoking Habit in Severe Obese after bariatric procedures. 119
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 118
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 118
Electronic Nose Technology in Respiratory Diseases 118
Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives 117
Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease. 116
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 116
Home Unattended Portable Monitoring and AutoCPAP Titration In Patients With High Risk for Moderate to Severe OSA. 114
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 114
Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management 113
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? 112
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 112
Predictive equations for CPAP titration in OSAS patients 111
HIGH DOSES OF M-TOR INHIBITORS MAY INDUCE PULMONARY PRO-FIBROTIC EFFECTS IN RENAL TRANSPLANT RECIPIENTS: RESULT OF A TRANSLATIONAL COMPARATIVE RESEARCH APPROACH BETWEEN PROGRAF VERSUS EVEROLIMUS 111
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 111
Abnormalities of Endothelin-1 metabolism in Pulmonary Embolism 110
EVEROLIMUS-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN BRONCHIAL AND PULMONARY CELLS: WHEN THE DOSAGE DOES MATTER IN TRANSPLANTATION 109
Hyperventilation In Patients With Pulmonary Arterial Hypertension Is Related To Increased Chemosensitivity 108
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 108
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study 108
An electronic nose in the diagnostic assessment of asthma in pediatric patients 107
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity 105
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency 105
Correlation between pulse transit time and microvascular impairment in OSAS patients 105
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 104
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 103
End points for pulmonary arterial hypertension: a way backward. 102
Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. 102
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 101
Interleukin-8 and soluble intercellular adhesion molecule 1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment 100
Excessive daytime sleepiness in women without OSA 100
Zafirlukast single oral dose pre-treatment prevents FEV1 drop after bronchial challenge in mild asthma 100
Influence of obstructive sleep apnea on endothelial function in obese patients. 99
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 99
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 98
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 97
Failure of noninvasive ventilation during hypercapnic exacerbation of chronic obstructive pulmonary disease: the role of chronic kidney diseases 97
Aumento dell'escrezione urinaria di Endotelina-1 in pazienti affetti da BPCO 95
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. 95
La presenza di apnea notturna peggiora il danno microcircolatorio sin dalle prime fasi dell'ipertensione arteriosa 93
Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP 93
Lower SNIP value is correlated to the need of intubation in Amyotrophic Lateral Sclerosis 92
Exhaled breath condensate as matrix for toluene detection: a preliminary study 92
Correlation between sniff nasal inspiratory pressure (snip) and amyotrophic lateral sclerosis functional rating scale (alsfrs) in als patients 90
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 90
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 90
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha 90
ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. 89
A successfully home-treated adverse reaction to cefepime in a geriatric patient 88
Endogenous Endothelin-1 production/excretion in patients with COPD 88
Cerebral heme-heme oxygenase-carbon monoxide-bilirubin system protects cerebral microvessels during seizures 87
Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation 87
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 87
Totale 12.594
Categoria #
all - tutte 76.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.136 32 134 5 89 49 76 40 67 75 56 170 343
2022/20231.952 266 185 120 204 259 300 17 197 337 8 26 33
2023/2024610 51 124 38 43 67 136 37 31 4 19 4 56
2024/20252.629 41 33 246 75 48 212 177 245 132 123 410 887
2025/20265.656 812 257 268 553 626 295 634 155 594 535 194 733
2026/2027122 122 0 0 0 0 0 0 0 0 0 0 0
Totale 18.417